SEARCH · Search NASA
Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Technique optimizes weight and speeds of disks in film-cooled turbines. Proposed iterative approach to design enables shaping of turbine disks partly according to temperature profiles. Suitable for design of advanced stationary, aircraft, and rocket turbines.
Computer program PROCSCAN developed to monitor profile of executable image during execution. Purpose to identify routines in which program is spending most of its time. PROSCAN very useful first step in optimization of program. PROSCAN samples program counter of executing image and compares its value to table of entry-point addresses to determine which subroutine is executing. Written in C (77 percent), Assembler (13 percent), and FORTRAN 77 (10 percent).
Global ozone monitoring experiment (GOME) level 2 products of total ozone column amounts have been generated on a routine operational basis since July 1996. These products and the level 1 radiance products are the major outputs from the ERS-2 ground segment GOME data processor (GDP) at DLR in Germany. Off-line scientific work has already shown the feasibility of ozone profile retrieval from GOME. It is demonstrated how the retrievals can be performed in an operational context. Height-resolved retrieval is based on the optimal estimation technique, #and cloud-contaminated scenes are treated in an equivalent reflecting surface approximation. The prototype must be able to handle GOME measurements routinely on a global basis. Requirements for the major components of the algorithm are described: this incorporates an overall strategy for operational height-resolved retrieval from GOME.
A document presents computational-simulation studies of a concept for stabilizing the attitude of a spacecraft during deployment of such structures as a solar sail or other structures supported by inflatable booms. Specifically, the solar sail considered in this paper is a square sail with inflatable booms and attitude control vanes at the corners. The sail inflates from its stowed configuration into a square sail with four segments and four vanes at the tips. Basically, the concept is one of controlling the rates of inflation of the booms to utilize in mass-distribution properties to effect changes in the system s angular momentum. More specifically, what was studied were the effects of staggering inflation of each boom by holding it at constant length for specified intervals between intervals of increasing length until full length is reached. The studies included sensitivity analyses of effects of variations in mass properties, boom lengths, rates of increase in boom length, initial rates of rotation of the spacecraft, and several asymmetries that could arise during deployment. The studies led to the conclusion that the final attitude of the spacecraft could be modified by varying the parameters of staggered inflation. Computational studies also showed that by feeding back attitude and attitude-rate measurements so that corrective action is taken during the deployment, the final attitude can be maintained very closely to the initial attitude, thus mitigating the attitude changes incurred during deployment and caused by modeling errors. Moreover, it was found that by optimizing the ratio between the holding and length-increasing intervals in deployment of a boom, one could cause deployment to track a desired deployment profile to place the entire spacecraft in a desired attitude at the end of deployment.
The GOES I-M satellite system is expected to provide continuous high resolution estimates of temperature and moisture profiles, winds from cloud motions, surface temperature, cloud properties, and precipitation for severe local storm and tropical cyclone events. The suggested operational schedule for the GOES I-M satellite emphasizes the observation frequencies, spatial coverage, spectral bands, etc. for the GOES I-M imager and sounder instruments that are expected to optimize the determination of the relevant meteorological parameters. During severe local storm events, the imager would be programmed to perform high frequency imaging (less than or= 3.5 min) for determining winds from cloud motions and for monitoring severe convection. In addition, the sounder would provide temperature and moisture profiles every hour over a 3000 X 3000 km domain during the antecedent stage or over a 1000 X 1000 km area every 10 minutes during the mature storm stage.
Four liners are investigated experimentally via tests in the NASA Langley Grazing Flow Impedance Tube. These include an axially-segmented liner and three liners that use reordering of the chambers. Chamber reordering is shown to have a strong effect on the axial sound pressure level profiles, but a limited effect on the overall attenuation. It is also shown that bent chambers can be used to reduce the liner depth with minimal effects on the attenuation. A numerical study is also conducted to explore the effects of a planar and three higher-order mode sources based on the NASA Langley Curved Duct Test Rig geometry. A four-segment liner is designed using the NASA Langley CDL code with a Python-based optimizer. Five additional liner designs, four with rearrangements of the first liner segments and one with a redistribution of the individual chambers, are evaluated for each of the four sources. The liner configuration affects the sound pressure level profile much more than the attenuation spectra for the planar and first two higher-order mode sources, but has a much larger effect on the SPL profiles and attenuation spectra for the last higher-order mode source. Overall, axially variable-depth liners offer the potential to provide improved fan noise reduction, regardless of whether the axially variable depths are achieved via a distributed array of chambers (depths vary from chamber to chamber) or a group of zones (groups of chambers for which the depth is constant).
A tool which generates optimal trajectory/control histories in an integrated manner is generically adapted to the treatment of single-stage-to-orbit air-breathing hypersonic vehicles. The methodology is implemented as a two point boundary value problem solution technique. Its use permits an assessment of an entire near-minimum-fuel trajectory and desired control strategy from takeoff to orbit while satisfying physically derived inequality constraints and while achieving efficient propulsive mode phasing. A simpler analysis strategy that partitions the trajectory into several boundary condition matched segments is also included to construct preliminary trajectory and control history representations with less computational burden than is required for the overall flight profile assessment. A demonstration was accomplished using a tabulated example (winged-cone accelerator) vehicle model that is combined with a newly developed multidimensional cubic spline data smoothing routine. A constrained near-fuel-optimal trajectory, imposing a dynamic pressure limit of 1000 psf, was developed from horizontal takeoff to 20,000 ft/sec relative air speed while aiming for a polar orbit. Previously unspecified propulsive discontinuities were located. Flight regimes demanding rapid attitude changes were identified, dictating control effector and closed-loop controller authority was ascertained after evaluating effector use for vehicle trim. Also, inadequacies in vehicle model representations and specific subsystem models with insufficient fidelity were determined based on unusual control characteristics and/or excessive sensitivity to uncertainty.
A 15-cm multipole thruster was operated on argon and xenon. The multipole approach used has been shown capable of low discharge losses and flat ion beam profiles with a minimum of redesign. This approach employs low magnetic field strengths and flat or cylindrical sheet-metal parts, hence is suited to rapid optimization and scaling. Only refractory metal cathodes were used in this investigation.
Some of the more important developments and progress in jet and fan noise reduction and flight effects are reviewed. Experiments are reported which show that nonaxisymmetric coannular nozzles have the potential to reduce jet noise for conventional and inverted velocity profiles. It is shown that an improved understanding of suppressive linear behavior, coupled with the new understanding of fan source noise, will soon allow the joint optimization of acoustic liner and fan design for low noise. It is also shown that fan noise source reduction concepts are applicable to advanced turboprops. Advances in inflow control device design are reviewed that appear to offer an adequate approach to the ground simulation of inflight fan noise.
A computer program was used to analyze the illuminated I-V characteristics of four sets of gallium arsenide (GaAs) solar cells irradiated with 1-MeV electrons and 10-MeV protons. It was concluded that junction regions (J sub r) dominate nearly all GaAs cells tested, except for irradiated Mitsubishi cells, which appear to have a different doping profile. Irradiation maintains or increases the dominance by J sub r. Proton irradiation increases J sub r more than does electron irradiation. The U.S. cells were optimized for beginning of life (BOL) and the Japanese for end of life (EOL). I-V analysis indicates ways of improving both the BOL and EOL performance of GaAs solar cells.
A group of 30 instrument-rated pilots was made to fly simulator approaches to three airports under conditions of low, medium, and high workload conditions. An analysis is presently conducted of the difference in discrete task scheduling between the group of 10 highest and 10 lowest performing pilots in the sample; this categorization was based on the mean of various flight-profile measures. The two groups were found to differ from each other only in terms of the time when specific events were conducted, and of the optimality of scheduling for certain high-priority tasks. These results are assessed in view of the relative independence of task-management skills from aircraft-control skills.
The Atmospheric Infrared Sounder (AIRS) is acting as a heritage and risk reduction instrument for the Cross-track lnfrared Sounder (CrIS) to be flown aboard the NPP and NPOESS satellites. The hyperspectral nature of AIRS and CrIS provides high-quality soundings that, along with their asynoptic observation time over North America, make them attractive sources to fill the spatial and temporal data voids in upper air temperature and moisture measurements for use in data assimilation and numerical weather prediction. Observations from AlRS can be assimilated either as direct radiances or retrieved thermodynamic profiles, and the Short-Term Prediction Research and Transition (SPORT) Center at NASA's Marshall Space Flight Center has used both data types to improve short-term (0-48h), regional forecasts. The purpose of this paper is to share SPORT'S experiences using AlRS radiances and retrieved profiles in regional data assimilation activities by showing that proper handling of issues-including cloud contamination and land emissivity characterization-are necessary to produce optimal analyses and forecasts.
Air quality control on the International Space Station (ISS) is a vital requirement for maintaining a clean environment for the crew and the hardware. This becomes a serious challenge in pressurized space compartments since no outside air ventilation is possible, and a larger particulate load is imposed on the filtration system due to lack of gravitational settling. The ISS Environmental Control and Life Support System (ECLSS) uses a filtration system that has been in use for over 14 years and has proven to meet this challenge. The heart of this system is a traditional High-Efficiency Particulate Air (HEPA) filter configured to interface with the rest of the life support elements and provide effective cabin filtration. The filter element for this system has a non-standard cross-section with a length-to-width ratio (LW) of 6.6. A filter test setup was designed and built to meet industry testing standards. A CFD analysis was performed to initially determine the optimal duct geometry and flow configuration. Both a screen and flow straighter were added to the test duct design to improve flow uniformity and face velocity profiles were subsequently measured to confirm. Flow quality and aerosol mixing assessments show that the duct flow is satisfactory for the intended leak testing. Preliminary leak testing was performed on two different ISS filters, one with known perforations and one with limited use, and results confirmed that the testing methods and photometer instrument are sensitive enough to detect and locate compromised sections of an ISS BFE.Given the engineering constraints in designing spacecraft life support systems, it is anticipated that non-industry standard filters will be required in future designs. This work is focused on developing test protocols for testing the ISS BFE filters, but the methodology is general enough to be extended to other present and future spacecraft filters. These techniques for characterizing the test duct and perform leak testing can be applied to conducting acceptance testing and inventory testing for future manned exploration programs with air revitalization filtration needs, possibly even for in-situ filter element integrity testing for extensively long-duration missions. We plan to address the unique needs for test protocols for crewed spacecraft particulate filters by preparing the initial version of a standard, to be documented as a NASA Technical Memorandum (TM).
One physically informative regularity of their otherwise heterogeneous ensemble, is that many Gamma-Ray Bursts consist of well defined pulses. To objectively quantify the temporal structure of BATSE bursts, we have developed an automatic modeling procedure that separates overlapping pulses and determines the energy-dependence of the pulse-shape parameters. No binning of photon arrival times is needed, so when applied to time-tagged events (TTE) the procedure captures variability information down to the shortest time scales present in the raw data. Maximizing the Bayesian likelihood function Pr(data/model) yields estimates of the model parameters, including the number of pulses present, and allows intercomparison of models of different forms. As with any nonlinear optimization, good initial guesses are crucial to avoid convergence to undesirable local minima. We find excellent initial pulse decompositions by wavelet-denoising a cumulative distribution of the raw photon arrival data; differentiation then gives a time profile mostly free of the systematic effects of degraded resolution (as in ordinary Fourier smoothing) and binning. We present statistical information on pulse rise-time, decay-time, peakedness, and amplitudes, plus their energy dependences - both within a single burst and for a large ensemble of bursts.
We present a lightweight starshade design that delivers the requisite profile figure accuracy with a compact stowed volume that permits launching both the occulter system (starshade and spacecraft) and a 1 to 2m-class telescope system on a single existing launch vehicle. Optimal figure stability is achieved with a very stiff and mass-efficient deployable structure design that has a novel configuration. The reference design is matched to a 1.1m telescope and consists of a 15m diameter inner disc and 24 flower-like petals with 7.5m length. The total tip-to-tip diameter of 30m provides an inner working angle of 75 mas. The design is scalable to accommodate larger telescopes and several options have been assessed. A proof of concept petal is now in production at JPL for deployment demonstrations and as a testbed for developing additional elements of the design. Future plans include developing breadboard and prototype hardware of increasing fidelity for use in demonstrating critical performance capabilities such as deployed optical edge profile figure tolerances and stability thereof.
In this paper we propose a reinforcement learning (RL) algorithm for path planning of Unmanned Aviation Vehicles (UAVs) under varying wind conditions. Solutions to UAV path planning problems are becoming increasingly necessary as autonomous UAVs continue to enter commercial and government spaces. Path-planning is inherently challenging, as UAVs need to account for dynamically changing flying conditions such as weather, obstacle or no-fly zones, degraded vehicle health, and off-nominal battery power consumption. Machine learning methods such as reinforcement learning (RL) have the potential to revolutionize how vehicles navigate in such uncertain environments. In this study, we compute UAV trajectories from a pre-determined starting position to a target cell within a 7X7 grid environment by optimizing parameters for mission assurance and safety limits in addition to the energy consumption and operation time. The UAV navigates the grid by taking actions to move in any of the eight cardinal and inter-cardinal directions, under constant thrust profile. The resultant UAV state is sampled from a probability distribution which accounts for the UAV’s action, local wind velocity, and the presence of obstacles or boundaries. As the unmanned airspace gets more complex due to multiple vehicles and environmental uncertainties, trade-offs between energy consumption, operation time, risk tolerance, and mission assurance need to be made. Our Markov Decision Process (MDP) environment model can capture any combination of these in the optimization objective, making it novel compared to other work in the field.
INTRODUCTION: Future spaceflight will require increased crew medical autonomy as exploration class missions expand in duration and distance from Earth, especially for Mars missions. As mission duration increases, it will be essential to have appropriate amounts of effective medication to ensure the maintenance of crew health and performance. Conversely, mass and volume constraints will become more severe as future spaceflight expands beyond low Earth orbit, where resupply is difficult or becomes impossible. These constraints thus convey an urgency to tailor medications for individual crewmembers and further examine appropriate dosing regimens. BACKGROUND: Precision Health is an exciting area of medicine focused on maintaining an individual’s health and performance through in-depth understanding of an individual’s unique clinical and environmental history, genetic makeup, and molecular profiles. This approach can be adapted to better predict, monitor, and address physiological responses to the spaceflight environment. A subset of this field is pharmacogenomics (PGX), the study of how the expressed genome impacts drug responses with the goal of prescribing the right dose of the right drug at the right time. Specifically, PGX testing provides valuable information on an individual’s precise allelic variations to guide physicians in making informed decisions on drug choice and dosing to avoid adverse events and maximize efficacy. The study goal was to identify which current space pharmacy drugs could be evaluated using PGX testing and to understand the potential impact on the health and wellness of the astronaut population. Additionally, we sought to evaluate clinically available FDA-approved PGX testing solutions to better understand its applicability. METHODS: A complete list of drugs on the ISS was analyzed for risk and likelihood of drug failure and PGX actionability. This analysis encompassed both astronauts’ personal medications, including supplements and over the counter drugs (n=151) contained in the ISS medical accessory kit (IMAK), and ISS MedKit formulary medications (n=95). Duplicate medications and different formulations were removed, which resulted in a total of 157 drugs used in the subsequent analysis. A 5x5 risk assessment table was produced by examining the likelihood of drug failure compared to the consequence of drug failure (LxC). Likelihood of individual drug failure was defined by whether existing processes are sufficient to prevent ineffective treatment or impactful side effect events, as ranked from 1 (very low, can easily be prevented) to 5 (very high, cannot be prevented) during a Mars mission. In contrast, the consequence of drug failure was defined by impact to safety, schedule, cost, or technical criteria and ranked from 1 (very low) to 5 (very high). An assessment of PGX reference laboratories is currently underway to evaluate sample requirements, benefit analysis (cost vs. utility of allele variant analysis), relevance to inflight medication usage, quality of reporting in enabling clinical application, and ease of integration into electronic medical records. RESULTS: Risk assessments (LxC 5x5 table) indicated 128 medications were in the green zone where risk is acceptable, with the remaining 29 of the medications in the yellow or red zone driven predominantly due to drug failure or safety concerns. We found that current PGX testing results could impact 21% of the total medications in the ISS MedKit and IMAK; of these, 9 medications currently have direct clinically actionable guidance available. Results of the clinical PGX solution evaluations as related to these medications will be presented. CONCLUSION: PGX testing has demonstrated clear benefits in terrestrial medicine and clinical environments for the selection of proper medications, avoiding adverse drug reactions, and maximizing drug efficacy. We propose that similar benefits would be bestowed on the astronaut and commercial spaceflight passenger population by performing preemptive preflight PGX testing to reduce risk of mission failure due to ineffective or toxic medications, improve drug efficacy, and further open the door to countermeasure research. For example, PGX results could allow tailoring of specific medications at optimal doses more precisely to each individual astronaut, particularly in areas of space motion sickness, sleep aids, and analgesics. An additional benefit is that PGX results could provide information for better planning of the components of a space pharmacy for deep space missions to be more effective and efficient in the utilization of limited pharmaceutical resources. Finally, while PGX testing of the astronaut corps is not currently conducted, this approach could provide immediate impact in support of mission success by reducing risks, optimizing astronaut performance, and providing valuable insights into long-term astronaut health. Such advancements in clinical decision making are important next steps in building dynamic individual risk profiles for astronauts, increasing selection of the best treatment choice, and providing tailored countermeasures for individual crewmembers.
INTRODUCTION: Future spaceflight will require increased crew medical autonomy as exploration class missions expanding duration and distance from Earth, especially for Mars missions. As mission duration increases, it will be even more essential to have appropriate amounts of effective medication to ensure the maintenance of crew health and performance. Conversely, mass and volume constraints will become more severe as future spaceflight expands beyond low Earth orbit, where resupply is difficult or becomes impossible. These constraints thus convey an urgency to further tailor medications included in the spacecraft formulary and increased examination of appropriate dosing regimens. BACKGROUND: Precision Health is an exciting area of cutting-edge research and medicine focused on maintaining an individual’s health and performance through in-depth understanding of an individual’s unique factors and molecular profiles. This approach can be adapted to better predict, monitor, and address physiological responses to the spaceflight environment. One example is the field of pharmacogenomics (PGX),the study of how the expressed genome impacts drug responses with the goal of prescribing the right dose of the right drug at the right time. Specifically, PGX testing provides valuable information on an individual’s precise allelic variations to guide physicians in making informed decisions on pharmaceutical choice and dosing to avoid adverse drug events and maximize pharmacological efficacy. The goal of this study was to evaluate which drugs in the current space pharmacy could be evaluated using PGX testing and to understand the potential impact on the health and wellness of the astronaut population. Additionally, we sought to evaluate clinically available FDA-approved PGX testing solutions to better understand its applicability. METHODS: A complete list of drugs onboard the International Space Station (ISS) was analyzed for risk and likelihood of drug failure and PGX actionability. This analysis encompassed both personal astronaut medications, including supplements and over the counter drugs (n=151) and ISS MedKit formulary medications (n=95). Duplicate medications and different formulations were removed, which resulted in 157 total drugs used in the subsequent analysis. A 5x5 risk assessment table was produced by examining the likelihood of drug failure compared to the consequence of drug failure. Likelihood of individual drug failure was defined by whether existing processes are sufficient to prevent adverse events, as ranked from 1 (very low, can easily be prevented) to 5 (very high, cannot be prevented) during a Mars mission. In contrast, the consequence of drug failure was defined by impact to safety, schedule, cost or technical and ranked from 1 (very low) to 5 (very high).A comprehensive assessment of commercially available PGX solutions is currently underway to evaluate specimen requirements, cost/benefit analysis (cost vs. number of alleles assessed), utility of variant analysis, relevance to inflight medication usage, quality of reporting in enabling clinical application, and ease of integration into electronic medical records. RESULTS: Risk assessments(LxC 5x5 table) indicated29medicationswere in the yellow or red zone driven predominantly by drug failure or safety concerns, with the remainder(n=128)of the medications in the green zone where risk is acceptable. We found that current PGX testing results could impact 21% of the total medications in the ISS MedKit and IMAK; of these, 9 medications currently have direct clinically actionable guidance available. Results of the clinical PGX solution evaluations as related to these medications will be presented. CONCLUSION: PGX testing has demonstrated clear benefits in terrestrial medicine and clinical environments for the selection of proper medications, avoiding adverse drug reactions, and maximizing drug efficacy. We propose that similar benefits would be bestowed on the astronaut and commercial spaceflight passenger population by performing preemptive pre-flight PGX testing to reduce risk of mission failure due to ineffective or toxic medications, improve targeting drug efficacy and safety, and further open the door to countermeasure research exploring PGX-related allelic variants. For example, PGX results could allow tailoring of specific medications at optimal doses more precisely to each individual astronaut, particularly in areas of space motion sickness, sleep aids, and analgesics. An additional benefit is that PGX results could provide information for better planning of the components of a space pharmacy for deep space missions to be more cost effective and more efficient in the utilization of limited pharmaceutical resources. Finally, while PGX testing of the astronaut corps is not currently conducted, this approach could provide immediate impact in support of mission success by reducing risks, optimizing astronaut performance, and providing valuable insights into long-term astronaut health. Such advancements in clinical decision making are important next steps in building dynamic individual risk profiles for astronauts, increasing crew autonomy and providing tailored countermeasures